Salbutamol (albuterol)

Short-acting β₂-agonist (SABA)

For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.

Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026

Salbutamol (albuterol) (Short-acting β₂-agonist (SABA)) – indications: Acute asthma – adults and adolescents, Acute asthma – children, Hyperkalaemia (moderate/severe) – adults (off-label). Weight-based dosing in mg and ml in the app, with sources.

Indications

Acute asthma – adults and adolescents
Acute asthma – children
Hyperkalaemia (moderate/severe) – adults (off-label)

Complete in the app

Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.

Open in the app Pocket book

Used in

Sources and guidelines

Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention.
Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, Update 2025 (inkl. Korrektur 11/2025: Salbutamol vernebelt für Kinder ≤ 5 J. 2,5 mg). ginasthma.org.
Global Initiative for Asthma (GINA). Summary Guide for Asthma Management and Prevention 2024. ginasthma.org.
Lott C et al. European Resuscitation Council Guidelines 2025: Special Circumstances in Resuscitation. Resuscitation 2025;215 Suppl 1:110753.